Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)

 Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)

Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)

Shots:

  • The launch is in based on the results of study evaluating reSET vs outpatient therapy alone showing improved recovery & abstinence from patients’ substances of abuse with increased retention time
  • reSET is a 12 week (90-day) FDA approved, digital cognitive behavioral therapy with medical mobile app for patients aged ≥, used in combination with outpatient clinician-delivered care, offering complete module treatments with face to face therapy sessions
  • Companies have also launched support center, reSET Connect Patient Service Center supporting patients to assess reSET app. In April, 2018 Sandoz collaborated with Pear to develop & commercialize reSET for patients with SUD

Click here to read full press release/ article | Ref: Novartis | Image: Mhealth Spot

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post